Allstocks.com's Bulletin Board Post New Topic  
my profile login | register | search | faq | forum home

  next oldest topic   next newest topic
» Allstocks.com's Bulletin Board » Stock Picks Only » MSITF

 - UBBFriend: Email this page to someone!    
Author Topic: MSITF
franske
New Member


Rate Member
Icon 1 posted      Profile for franske     Send New Private Message       Edit/Delete Post 
Answer from the National Institute For Communicable Diseases.
I asked if they could confirm this PR.

Maybe it's all true after all!!!
wouldn't that be something !!!


Dear Mr. Xxxxx, yes I can confirm that the NICD evaluated the kit and the results are correct. The company should be able to provide you with a report that we provided to them for your scrutiny. The results however, are not necessarily unique to the kit and does not mean there is necessarily a competitive advantage against other kits.

Sincerely

Adrian Puren


--------------------------------------------------------------------------------

From: Xxxxxx Xxxxx [mailto:xxxxxx.xxxxx*skynet.be]
Sent: 11 January 2007 08:32
To: Adrian Puren
Subject: Re: Enquiry: VScan HIV test kits


Hi Adrian,


is it possible for U to confirm that Medical Services International Inc. did complete testing theirs HIV Vscan testkit with

the National Institute For Communicable Diseases?

They claim it to be true per pr on dec 27, 2006.

I'm an investor from Belgium and this is the first time in years that Medical Services gives a pr that can be confirmed (true or not true).

I really would like to hear from U again on this matter.


Thanks in advance.


Sincerely,

Xxxxxx Xxxxx


-------------------------------------------------------------------------------- --------------------------------------------------------------

Medical Services Completes Further Testing of Its VScan HIV Test Kit With Excellent Results

EDMONTON, Alberta, Dec. 27 /PRNewswire-FirstCall/ -- Medical Services International Inc. (Pinksheets: MSITF) is pleased to announce that it has completed additional testing of its VScan HIV test kit with the National Institute For Communicable Diseases. The regulatory agency tested 500 VScan HIV test kits with the following test results: Sensitivity- 100%, Specificity- 100%. It is very rare for a test kit to test with such accuracy. The final report also refers to ease of performance with a rating of 'very easy to use' and suitability for use rating as 'very suitable.' A report of this magnitude from an agency with the excellent reputation of the National Institute For Communicable Diseases confirms the reliability of the VScan HIV test kit.

This report once again demonstrates the accuracy of the VScan HIV test kit. The many excellent independent test results are now being included in new updated marketing brochures and will be included on the new website that is currently being constructed. It is felt that reports of this magnitude combined with additional approvals in more countries combined with the new website will significantly increase kit sales in 2007. The Company is looking forward to an exceptional new year.

About VScan

The VScan rapid test kit is a single use, disposable, accurate, cost effective, easy to use, test for the screening of HIV 1&2, Hepatitis B&C, Tuberculosis (TB), Dengue Fever, West Nile, Syphilis, Malaria and Prostate Cancer. The kits cannot be sold in Canada.

Medical Services International Inc. trades in the United States on the NQB Pinksheets under the symbol 'MSITF.' For further information, please contact Robert Talbot at (780) 430 6363 or http://www.medicalservicesintl.com or http://www.minerva-biotech.com.

NOTE: Certain statements in this press release are 'forward-looking statements' within the meaning of the Private Securities Act of 1995. Such statements involve known and unknown risks, uncertainties and other factors that may cause results to differ materially. Such risks, uncertainties and other factors include but are not limited to new economic conditions, risk in product development, market acceptance of new products and continuing product demand, level of competition and other factors described in Company reports and other filings with regulatory bodies.

SOURCE Medical Services International Inc.


Source: PR Newswire (December 27, 2006 - 12:06 AM EST)
-------------------------------------------------------------------------------- -----------------------------------------------------------------


----- Original Message -----

From: Adrian Puren

To: xxxxxx.xxxxx*skynet.be

Sent: Wednesday, January 10, 2007 8:36 AM

Subject: Enquiry: VScan HIV test kits


Dear Sir/Madam, I would be quite prepared to respond to your enquiry on the above but would like to better understand the nature of your enquiry.

Thank you,

Adrian Puren

Deputy Director

National Institute for Communicable Diseases


The views expressed in this email are, unless otherwise stated, those of the author and not those of the National Health Laboratory Services or its management. The information in this e-mail is confidential and is intended solely for the addressee.
Access to this e-mail by anyone else is unauthorized. If you are not the intended recipient, any disclosure, copying, distribution or any action taken or omitted in reliance on this, is prohibited and may be unlawful.
Whilst all reasonable steps are taken to ensure the accuracy and integrity of information and data transmitted electronically and to preserve the confidentiality thereof, no liability or responsibility whatsoever is accepted if information or data is, for whatever reason, corrupted or does not reach its intended destination.

Posts: 4 | From: Belgium | Registered: Oct 2006  |  IP: Logged | Report this post to a Moderator
   

Post New Topic   Close Topic   Feature Topic   Move Topic   Delete Topic next oldest topic   next newest topic
 - Printer-friendly view of this topic
Hop To:


Contact Us | Allstocks.com Message Board Home

1997 - 2013 Allstocks.com. All rights reserved.

Powered by Infopop Corporation
UBB.classic™ 6.7.2

Share